A quality assessment tool to evaluate tocolytic studies

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue SUPPL. 3, 2006, Pages 96-99

  Lamont, R F ^a  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

agonists; Atosiban; Meta analyses; Nifedipine; Systematic reviews

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; UTERUS SPASMOLYTIC AGENT;

CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG USE; HUMAN; META ANALYSIS; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TABLET FORMULATION; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ADRENERGIC BETA-AGONISTS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; META-ANALYSIS AS TOPIC; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; QUALITY ASSURANCE, HEALTH CARE; TOCOLYTIC AGENTS;

EID: 33845594102     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01132.x     Document Type: Review

References (25)

1. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
2. Leveno KJ, Cunningham FG. Beta-adrenergic agonists for preterm labor. N Engl J Med 1992;327:349-51.
3. Lamont RF. The pathophysiology of pulmonary oedema with the use of beta-agonists. BJOG 2000;107:439-44.
4. Lamont RF. The development and introduction of anti-oxytocic tocolytics. BJOG 2003;110(Suppl 20):108-12.
5. Akerlund M, Stromberg P, Hauksson A, Andersen LF, Lyndrup J, Trojnar J, et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 1987;94:1040-4.
6. Anderson L-F, Lyndrup J, Akerlund M, Melin P. Oxytocin receptor blockade: a new principle in the treatment of preterm labor. Am J Perinatol 1989;6:196-9.
7. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994;170:474-8.
8. Goodwin TM, Valenzuela GJ, Silver H, Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol 1996;88:331-6.
9. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173-83.
10. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191-9.
11. European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001;80:413-22.
12. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177-85.
13. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001;108:133-42.
14. Royal College of Obstetricians and Gynaecologists Clinical Guidelines No. 1(B). 2002. [www.rcog.org.uk/resources/Public/pdf/Tocolytic_Drugs_No1(B).pdf]. Accessed 06 August.
15. Oei SG, Mol BW, de Kleine MJ, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999;78:783-8.
16. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001;97:840-7.
17. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2002;4:CD000246.
18. King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Aust N Z J Obstet Gynaecol 2003;43:192-8.
19. Tsatsaris V, Carbonne B, Papatsonis D, Goffinet F. Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet Gynecol Scand 2000;79:618-19.
20. Koks CA, Brolmann HA, de Kleine MJ, Manger PA. A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur J Obstet Gynecol Reprod Biol 1998;77:171-6.
21. Larmon JE, Ross BS, May WL, Dickerson GA, Fischer RG, Morrison JC. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol 1999;181:1432-7.
22. Weerakul W, Chittacharoen A, Suthutvoravut S. Nifedipine versus terbutaline in management of preterm labor. Int J Gynaecol Obstet 2002;76:311-13.
23. Papatsonis DNM, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:1023-4.
24. Khan K, Kunz R, Kleijnen J, Antes G. Systematic Reviews to Support Evidence-based Medicine: How to Review and Apply Findings of Healthcare Research. 1st edn. UK: Royal Society of Med Press, 2003.
25. Lamont RF, Khan KS, Beattie B, Cabero Roura L, Di Renzo GC, Dudenhausen JW, et al. The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J Perinat Med 2005;33:287-95.